Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/1999

01-01-1999

Effect of fenretinide on bone mineral density and metabolism in women with early breast cancer

Authors: Andrea Decensi, Rosalba Torrisi, Alberto Gozza, Gianluca Severi, Gianfilippo Bertelli, Vincenzo Fontana, Floriana Pensa, Lauro Carozzo, Attilio Traverso, Sabatino Milone, Dario Dini, Alberto Costa

Published in: Breast Cancer Research and Treatment | Issue 2/1999

Login to get access
Metadata
Title
Effect of fenretinide on bone mineral density and metabolism in women with early breast cancer
Authors
Andrea Decensi
Rosalba Torrisi
Alberto Gozza
Gianluca Severi
Gianfilippo Bertelli
Vincenzo Fontana
Floriana Pensa
Lauro Carozzo
Attilio Traverso
Sabatino Milone
Dario Dini
Alberto Costa
Publication date
01-01-1999
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/1999
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1006160523497

Other articles of this Issue 2/1999

Breast Cancer Research and Treatment 2/1999 Go to the issue

OriginalPaper

Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)

OriginalPaper

The expression of variant exon v7–v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer

OriginalPaper

Effect of thermal variables on human breast cancer in cryosurgery

OriginalPaper

Serum VEGF levels in women with a benign breast tumor or breast cancer

OriginalPaper

Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas

OriginalPaper

Comparative effect of chlormadinone acetate and diethylstilbestrol as promoters in mammary tumorigenesis of rats irradiated with γ-rays during lactation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits